Ambry Genetics Corp-医療機器分野:企業M&A・提携分析

◆英語タイトル:Ambry Genetics Corp - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011256
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ambry Genetics Corp (Ambry Genetics) is a biotechnology company that offers genetic testing services. The company offers clinical diagnostics services, which include tests, forms, billing, managed care, order kits, reporting, licenses, family studies program, variant classification and secure file upload. It offers clinical resources such as cancer test overview videos, webinars, clinical tools, clinician guides, other publications, and ambryport 2.0 tutorial videos. The company also provides patient resources for cancer, cardiology, exome, general genetics, neurology, and microarray. Ambry Genetics is headquartered in Aliso Viejo, California, the US.

Ambry Genetics Corp – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Ambry Genetics Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Ambry Genetics Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Ambry Genetics Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Ambry Genetics Corp, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Ambry Genetics Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Ambry Genetics Corp, Medical Equipment, Deal Details 11
Asset Purchase 11
Ambry Genetics Acquires ThunderStorm System From RainDance Technologies 11
Partnerships 12
Ambry Genetics Partners with Beth Israel Deaconess Medical Center, University of Pittsburgh and HonorHealth Research Institute 12
Cell Line Genetics Enters Into Co-Marketing Agreement With Ambry Genetics 13
LABS Enters Into An Agreement With Ambry Genetics 14
RainDance Technologies Enters Into Collaboration With Ambry Genetics 15
Acquisition 16
Konica Minolta Acquires Ambry Genetics 16
Ambry Genetics Acquires Progeny Software 18
Ambry Genetics Corp – Key Competitors 19
Ambry Genetics Corp – Key Employees 20
Ambry Genetics Corp – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Strategy And Business Planning 22
Feb 18, 2016: Ambry Genetics Unveils Its Super Lab, One of the Largest, Most State-of-the-Art Commercial Laboratories in the World 22
Corporate Communications 24
Mar 24, 2016: Charles Dunlop of Ambry Genetics Assumes Role of President; Dr. Aaron Elliott Named CEO 24
Government and Public Interest 25
Apr 18, 2017: Ambry Genetics Recruits Patient Cohorts to Discover New Links between Genes and Autism 25
Product News 26
Dec 05, 2017: Ambry Presents Research Expanding Our Understanding of Gene Disease Relationships at the San Antonio Breast Cancer Symposium 26
Nov 28, 2017: Ambry Genetics’ Mitochondrial Disease Research May Help Develop Treatments Sooner 27
Oct 16, 2017: Ambry Presents Scientific Discovery to Enhance Clinical Practice at American Society for Human Genetics Annual Meeting 28
Sep 12, 2017: Ambry Announces New Research Grant Program in their Commitment Towards Advancing Science and Research at NSGC 2017 29
Jun 06, 2017: Ambry Launches Innovative Tumor/Germline Testing to Help Clinicians Guide Patient Treatment 30
Jun 02, 2017: Ambry to Present New Data Showing That up to 30% of Cancer Risk Carriers Are Missed by Current Testing Guidelines at the 2017 ASCO Meeting 32
Sep 06, 2016: Ambry Genetics and Collaborators Publish Vital Processes and Data to Better Understand New Gene Associated with Unexplained Neurodevelopmental Disorder 34
Jun 01, 2016: Ambry Genetics and Prominent Oncology Research Collaborators to Share New Hereditary Cancer Data at Upcoming American Society of Clinical Oncology Annual Meeting 35
Mar 08, 2016: Ambry Genetics Launches AmbryShare, the Largest Disease-Specific Public Database of Sequenced Human Genomes, Increasing the Understanding of Hereditary Breast and Ovarian Cancer 10 Fold 37
Jan 20, 2016: Ambry Genetics Launches New Neurodevelopmental Genetic Testing Panel 39
Other Significant Developments 40
Oct 24, 2017: Ambry Genetics Advances Patient Care through Telemedicine Genetic Counseling Services & PWNHealth Partnership 40
Sep 14, 2017: FDNA Teams with World’s Top Genetic Labs to Advance Genetic Testing for Rare Diseases 41
Sep 14, 2017: Ambry Genetics Announces Integration with FDNA to Advance Precision Medicine 42
Sep 12, 2017: Ambry Genetics & NorthShore University HealthSystem Partner to Accelerate Precision Medicine in Preventive Care 43
Jan 14, 2016: Ambry Genetics Launches Cost-free, Cloud-based Software to Help Clinicians and Researchers Maximize Genetic and Family History Data 44
Appendix 45
Methodology 45
About GlobalData 45
Contact Us 45
Disclaimer 45

List of Tables
Ambry Genetics Corp, Medical Equipment, Key Facts 2
Ambry Genetics Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Ambry Genetics Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Ambry Genetics Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Ambry Genetics Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Ambry Genetics Corp, Deals By Market, 2011 to YTD 2017 9
Ambry Genetics Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Ambry Genetics Acquires ThunderStorm System From RainDance Technologies 11
Ambry Genetics Partners with Beth Israel Deaconess Medical Center, University of Pittsburgh and HonorHealth Research Institute 12
Cell Line Genetics Enters Into Co-Marketing Agreement With Ambry Genetics 13
LABS Enters Into An Agreement With Ambry Genetics 14
RainDance Technologies Enters Into Collaboration With Ambry Genetics 15
Konica Minolta Acquires Ambry Genetics 16
Ambry Genetics Acquires Progeny Software 18
Ambry Genetics Corp, Key Competitors 19
Ambry Genetics Corp, Key Employees 20
Ambry Genetics Corp, Subsidiaries 21

★海外企業調査レポート[Ambry Genetics Corp-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Saudi Chemical Company (2230):企業の財務・戦略的SWOT分析
    Saudi Chemical Company (2230) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Neurones SA (NRO):企業の財務・戦略的SWOT分析
    Neurones SA (NRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Henry Ford Health System:企業の戦略的SWOT分析
    Henry Ford Health System - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Shv Holdings N.V.
    Shv Holdings N.V. - Strategy, SWOT and Corporate Finance Report Summary Shv Holdings N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • TETRA Technologies Inc Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    TETRA Technologies Inc Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary TETRA Technologies Inc (TETRA) is an oil and gas company that offers completion fluids and associated products and services. The company’s services comprise compression services, fluid, filtration …
  • Valeo SA (FR):企業の財務・戦略的SWOT分析
    Valeo SA (FR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Immunicum AB (IMMU)-製薬・医療分野:企業M&A・提携分析
    Summary Immunicum AB (Immunicum) is a biopharmaceutical company that develops immuno-oncology therapies for the treatment of solid tumors. The company’s products include COMBIG, CD70, SUBCUVAX and adenovirusvector. Its SUBCUVAX is in preclinical trials in combination with the adenovirus vector for t …
  • Redcape Hotel Group:企業の戦略・SWOT・財務情報
    Redcape Hotel Group - Strategy, SWOT and Corporate Finance Report Summary Redcape Hotel Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Thomas Cook Group plc (TCG):企業の財務・戦略的SWOT分析
    Thomas Cook Group plc (TCG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • MegaChips Corp (6875):企業の財務・戦略的SWOT分析
    MegaChips Corp (6875) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • NutriSystem Inc:企業の戦略的SWOT分析
    NutriSystem Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • RCR Tomlinson Ltd (RCR):企業の財務・戦略的SWOT分析
    RCR Tomlinson Ltd (RCR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Obagi Medical Products Inc-製薬・医療分野:企業M&A・提携分析
    Summary Obagi Medical Products Inc (Obagi), a subsidiary of Valeant Pharmaceuticals International Inc is a drug company that manufactures, sells, and markets skin care systems. The company provides products that include targeted solutions, tretinoin products, transformation systems, skin recovery, i …
  • Nippon Life Insurance Company:企業の戦略・SWOT・財務情報
    Nippon Life Insurance Company - Strategy, SWOT and Corporate Finance Report Summary Nippon Life Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Syndax Pharmaceuticals Inc (SNDX)-医療機器分野:企業M&A・提携分析
    Summary Syndax Pharmaceuticals Inc (Syndax) is aclinical stage biopharmaceutical company that develops and commercializes therapies for multiple cancer indications. The company’s lead product candidate, entinostat, an oral, small molecule drug candidate, which is in phase 3 clinical trial used for t …
  • Nachi-Fujikoshi Corp (6474):企業の財務・戦略的SWOT分析
    Nachi-Fujikoshi Corp (6474) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Omega Protein Corporation:企業の戦略・SWOT・財務分析
    Omega Protein Corporation - Strategy, SWOT and Corporate Finance Report Summary Omega Protein Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Chemical Company of Malaysia Bhd (CCM):企業の財務・戦略的SWOT分析
    Chemical Company of Malaysia Bhd (CCM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Wienerberger AG:企業のM&A・事業提携・投資動向
    Wienerberger AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Wienerberger AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Pinnacle Entertainment Inc:戦略・SWOT・企業財務分析
    Pinnacle Entertainment Inc - Strategy, SWOT and Corporate Finance Report Summary Pinnacle Entertainment Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆